EP2319558B1 — Mems device for delivery of therapeutic agents
Assigned to University of Southern California USC · Expires 2014-05-21 · 12y expired
What this patent protects
An implantable device (200) for delivering a therapeutic agent to a patient is provided. The device includes a reservoir (300) configured to contain a liquid comprising the therapeutic agent. The device further includes a cannula (110) in fluid communication with the reservoir. T…
USPTO Abstract
An implantable device (200) for delivering a therapeutic agent to a patient is provided. The device includes a reservoir (300) configured to contain a liquid comprising the therapeutic agent. The device further includes a cannula (110) in fluid communication with the reservoir. The cannula has an outlet configured to be in fluid communication with the patient. The device further includes a first electrode (320) and a second electrode (330), at least one of the first electrode and the second electrode is planar. The device further includes a material in electrical communication with the first and second electrodes. A voltage applied between the first electrode and the second electrode produces gas from the material, the gas forcing the liquid to flow from the reservoir to the outlet.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.